2MZI

NMR Solution Structure of the PRO Form of Human Matrilysin (proMMP-7) in Complex with Anionic Membrane

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 50 mM 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 100 mM 1,2-DIHEXANEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 3 mM CHOLEST-5-EN-3-YL HYDROGEN SULFATE, 20 mM imidazole, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
2	3D 1H-13C NOESY	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 50 mM 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 100 mM 1,2-DIHEXANEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 3 mM CHOLEST-5-EN-3-YL HYDROGEN SULFATE, 20 mM imidazole, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide	90% H2O/10% D2O		6.6		310
3	2D 1H-15N HSQC, CPMG	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 50 mM 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 100 mM 1,2-DIHEXANEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 3 mM CHOLEST-5-EN-3-YL HYDROGEN SULFATE, 20 mM imidazole, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide, 1.5 mM 1-palmitoyl-2-stearoyl-(14-doxyl)-sn-glycero-3-phosphocholine, 1.5 mM 1,2-dipalmitoyl-sn-glycero-3-phospho(tempo)choline	90% H2O/10% D2O		6.6		310
4	2D 1H-13C HSQC, CPMG	0.4 mM [U-100% 15N, U-100% 13CH3 (ILV)] proMMP-7(E195A), 50 mM 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 100 mM 1,2-DIHEXANEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, 3 mM CHOLEST-5-EN-3-YL HYDROGEN SULFATE, 20 mM imidazole, 10 mM CaCl2, 20 uM ZnCl2, 10 mM beta-mercaptoethanol, 0.02 % sodium azide, 1.5 mM 1-palmitoyl-2-stearoyl-(14-doxyl)-sn-glycero-3-phosphocholine, 1.5 mM 1,2-dipalmitoyl-sn-glycero-3-phospho(tempo)choline	90% H2O/10% D2O		6.6		310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
molecular dynamics	Energy minimisation. 100ps NVT equilibration. 1ns NPT equilibration. 20ns time-averaged restrained MD.	TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	10000
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.1	Bruker Biospin
2	processing	TopSpin	3.1	Bruker Biospin
3	peak picking	Analysis	2.4	CCPN
4	chemical shift assignment	Analysis	2.4	CCPN
5	structure solution	HADDOCK	2.1	Alexandre Bonvin
6	refinement	GROMOS	4.5.7	van Gunsteren and Berendsen

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.